These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, Halliday HL, Versmold HT, Moriette G, Jorch G. N Engl J Med; 1994 Apr 28; 330(17):1173-8. PubMed ID: 8139627 [Abstract] [Full Text] [Related]
19. A management guideline to reduce the frequency of blood transfusion in very-low-birth-weight infants. Rabe H, Alvarez JR, Lawn C, Seddon P, Amess PN. Am J Perinatol; 2009 Mar 28; 26(3):179-83. PubMed ID: 19085812 [Abstract] [Full Text] [Related]
20. Recombinant human erythropoietin in anemia of prematurity. Whitehall JS, Patole SK, Campbell P. Indian Pediatr; 1999 Jan 28; 36(1):17-27. PubMed ID: 10709119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]